Change in CXCL10 on treatment with methotrexate similar to that reported with infliximab: comments on the article by Eriksson et al.
Rheumatology Unit, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh , India.
V
V
Dhir
A
A
Sandhu
N
N
Gupta
A
A
Sharma
S
S
Sharma
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy*; D018925:Chemokines / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D018925:Chemokines; D014409:Tumor Necrosis Factor-alpha